Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging.
Leyton CE, Villemagne VL, Savage S, Pike KE, Ballard KJ, Piguet O, Burrell JR, Rowe CC, Hodges JR.
Brain. 2011 Oct;134(Pt 10):3030-43. Epub 2011 Sep 9.
Related citations
Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.
Bohnen NI, Müller ML, Zarzhevsky N, Koeppe RA, Bogan CW, Kilbourn MR, Frey KA, Albin RL.
Brain. 2011 Aug;134(Pt 8):2358-65. Epub 2011 Jun 8.
Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.
Masilamoni GJ, Bogenpohl JW, Alagille D, Delevich K, Tamagnan G, Votaw JR, Wichmann T, Smith Y.
Brain. 2011 Jul;134(Pt 7):2057-73.
Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease.
de Souza LC, Corlier F, Habert MO, Uspenskaya O, Maroy R, Lamari F, Chupin M, Lehéricy S, Colliot O, Hahn-Barma V, Samri D, Dubois B, Bottlaender M, Sarazin M.
Brain. 2011 Jul;134(Pt 7):2036-43.
Atrophy, hypometabolism and white matter abnormalities in semantic dementia tell a coherent story.
Acosta-Cabronero J, Patterson K, Fryer TD, Hodges JR, Pengas G, Williams GB, Nestor PJ.
Brain. 2011 Jul;134(Pt 7):2025-35. Epub 2011 Jun 6.
Infarction of 'non-core-non-penumbral' tissue after stroke: multivariate modelling of clinical impact.
Alawneh JA, Jones PS, Mikkelsen IK, Cho TH, Siemonsen S, Mouridsen K, Ribe L, Morris RS, Hjort N, Antoun N, Gillard JH, Fiehler J, Nighoghossian N, Warburton EA, Ostergaard L, Baron JC.
Brain. 2011 Jun;134(Pt 6):1765-76.
Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden.
Drzezga A, Becker JA, Van Dijk KR, Sreenivasan A, Talukdar T, Sullivan C, Schultz AP, Sepulcre J, Putcha D, Greve D, Johnson KA, Sperling RA.
Brain. 2011 Jun;134(Pt 6):1635-46. Epub 2011 Apr 13.
Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography.
Burke JF, Albin RL, Koeppe RA, Giordani B, Kilbourn MR, Gilman S, Frey KA.
Brain. 2011 Jun;134(Pt 6):1647-57. Epub 2011 May 9.
Impaired sequence learning in dystonia mutation carriers: a genotypic effect.
Carbon M, Argyelan M, Ghilardi MF, Mattis P, Dhawan V, Bressman S, Eidelberg D.
Brain. 2011 May;134(Pt 5):1416-27. Epub 2011 Apr 22.
Neural correlates of cognitive impairment in posterior cortical atrophy.
Kas A, de Souza LC, Samri D, Bartolomeo P, Lacomblez L, Kalafat M, Migliaccio R, Thiebaut de Schotten M, Cohen L, Dubois B, Habert MO, Sarazin M.
Brain. 2011 May;134(Pt 5):1464-78. Epub 2011 Apr 7.
Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.
Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW; Alzheimer's Disease NeuroImaging Initiative.
Brain. 2011 Apr;134(Pt 4):1077-88. Epub 2011 Mar 22.
Long-term consolidation of declarative memory: insight from temporal lobe epilepsy.
Tramoni E, Felician O, Barbeau EJ, Guedj E, Guye M, Bartolomei F, Ceccaldi M.
Brain. 2011 Mar;134(Pt 3):816-31.
Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.
Melzer TR, Watts R, MacAskill MR, Pearson JF, Rüeger S, Pitcher TL, Livingston L, Graham C, Keenan R, Shankaranarayanan A, Alsop DC, Dalrymple-Alford JC, Anderson TJ.
Brain. 2011 Mar;134(Pt 3):845-55. Epub 2011 Feb 9.
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group.
Brain. 2011 Mar;134(Pt 3):798-807. Epub 2011 Feb 9.
Brain microbleeds and Alzheimer's disease: innocent observation or key player?
Cordonnier C, van der Flier WM.
Brain. 2011 Feb;134(Pt 2):335-44. Epub 2011 Jan 21. Review.
Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.
Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A.
Brain. 2011 Jan;134(Pt 1):301-17. Epub 2010 Dec 13.
Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.
Knight WD, Okello AA, Ryan NS, Turkheimer FE, Rodríguez Martinez de Llano S, Edison P, Douglas J, Fox NC, Brooks DJ, Rossor MN.
Brain. 2011 Jan;134(Pt 1):293-300. Epub 2010 Nov 16.
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction.
Pavese N, Metta V, Bose SK, Chaudhuri KR, Brooks DJ.
Brain. 2010 Nov;133(11):3434-43. Epub 2010 Sep 30.
Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.
Hirano S, Shinotoh H, Shimada H, Aotsuka A, Tanaka N, Ota T, Sato K, Ito H, Kuwabara S, Fukushi K, Irie T, Suhara T.
Brain. 2010 Jul;133(Pt 7):2058-68. Epub 2010 Jun 17.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on